Geode Capital Management
ZSAN

Geode Capital Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Geode Capital Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,723
Closed -$203K – 5088
2022
Q1 		$203K Hold
25,723
– – ﹤0.01% 4377
2021
Q4 		$423K Hold
25,723
– – ﹤0.01% 4135
2021
Q3 		$647K Buy
25,723
+376
+1% +$9.75K ﹤0.01% 3907
2021
Q2 		$842K Buy
25,347
+2,151
+9% +$69.3K ﹤0.01% 3695
2021
Q1 		$1.01M Buy
23,196
+6,339
+38% +$266K ﹤0.01% 3562
2020
Q4 		$310K Buy
16,857
+6,493
+63% +$127K ﹤0.01% 3746
2020
Q3 		$587K Buy
10,364
+397
+4% +$18.5K ﹤0.01% 3385
2020
Q2 		$298K Buy
9,967
+6,759
+211% +$191K ﹤0.01% 3546
2020
Q1 		$63K Hold
3,208
– – ﹤0.01% 3883
2019
Q4 		$170K Hold
3,208
– – ﹤0.01% 3851
2019
Q3 		$175K Hold
3,208
– – ﹤0.01% 3820
2019
Q2 		$367K Buy
3,208
+870
+37% +$103K ﹤0.01% 3580
2019
Q1 		$390K Hold
2,338
– – ﹤0.01% 3532
2018
Q4 		$173K Hold
2,338
– – ﹤0.01% 3715
2018
Q3 		$334K Buy
2,338
+158
+7% +$23.1K ﹤0.01% 3587
2018
Q2 		$311K Buy
+2,180
New +$328K ﹤0.01% 3585
2018
Q1 		– Sell
-268
Closed -$97K – 4093
2017
Q4 		$97K Hold
268
– – ﹤0.01% 3824
2017
Q3 		$154K Hold
268
– – ﹤0.01% 3728
2017
Q2 		$264K Buy
268
+206
+332% +$213K ﹤0.01% 3585
2017
Q1 		$82K Buy
+62
New +$74.8K ﹤0.01% 3863

Other funds holding ZSAN

CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Geode Capital Management's ZSAN Position: Q2 2022 in Review

Geode Capital Management sold out of Zosano Pharma Corporation (ZSAN) in Q2 2022, closing a stake of 25,723 shares — an estimated $203K sold.

Geode Capital Management first reported a position in ZSAN in Q1 2017 and held it in 20 quarters. The position peaked at $1.01M in Q1 2021. 3 funds tracked by Wall St. Rank hold ZSAN as of Q2 2022.

  • Geode Capital Management reported no remaining Zosano Pharma Corporation position as of Q2 2022 after selling out during the quarter.
  • Geode Capital Management sold 25,723 Zosano Pharma Corporation shares in Q2 2022, an estimated $203K.
  • Geode Capital Management first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 20 quarters.
  • Geode Capital Management's Zosano Pharma Corporation position peaked at $1.01M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2022.

Based on Geode Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.